CAPRISA 003: Timing of Antiretroviral Initiation in HIV-TB Co-infected Patients—The SAPiT Trial

about

CAPRISA 003: Timing of Antiretroviral Initiation in HIV-TB Co-infected Patients—The SAPiT Trial

Item

http://www.wikidata.org/entity/Q57980350

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2017

@uk

name

CAPRISA 003: Timing of Antiret ...... ected Patients—The SAPiT Trial

@en

CAPRISA 003: Timing of Antiret ...... ected Patients—The SAPiT Trial

@nl

type

Item

label

CAPRISA 003: Timing of Antiret ...... ected Patients—The SAPiT Trial

@en

CAPRISA 003: Timing of Antiret ...... ected Patients—The SAPiT Trial

@nl

prefLabel

CAPRISA 003: Timing of Antiret ...... ected Patients—The SAPiT Trial

@en

CAPRISA 003: Timing of Antiret ...... ected Patients—The SAPiT Trial

@nl

P1476

CAPRISA 003: Timing of Antiret ...... ected Patients—The SAPiT Trial

@en

P2093

Andy Gray

http://www.w3.org/2001/XMLSchema#string

Kogie Naidoo

http://www.w3.org/2001/XMLSchema#string

Nesri Padayatchi

http://www.w3.org/2001/XMLSchema#string

Salim S. Abdool Karim

http://www.w3.org/2001/XMLSchema#string

P2860

Issues in the treatment of active tuberculosis in human immunodeficiency virus-infected patients.

Timing of initiation of antiretroviral drugs during tuberculosis therapy.

Initiating antiretrovirals during tuberculosis treatment: a drug safety review.

Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis.

Integration of antiretroviral therapy with tuberculosis treatment.

Cost-Effectiveness of Initiating Antiretroviral Therapy at Different Points in TB Treatment in HIV-TB Coinfected Ambulatory Patients in South Africa.

The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial.

Improved survival in multidrug-resistant tuberculosis patients receiving integrated tuberculosis and antiretroviral treatment in the SAPiT Trial

The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosis

Changes to antiretroviral drug regimens during integrated TB-HIV treatment: results of the SAPiT trial

P304

107-120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-3-319-47518-9_8

http://www.w3.org/2001/XMLSchema#string

P50

Anneke C. Grobler

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime